Schedule 13G ownership disclosure

CALADRIUS BIOSCIENCES ORD

Security class unavailable · CUSIP: 128058203

Event date: 2017-03-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,059,322
Percent of class
11.8500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-018804
Form type
SC 13G/A
Filer
LISATA THERAPEUTICS, INC.
CIK
CIK 320017
Filed
Mar 23, 2017
Reporting period
Mar 22, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub